Skip to main content
padlock icon - secure page this page is secure

Time-Resolved Luminescence-Based Assay for Thyroglobulin

Buy Article:

$106.34 + tax (Refund Policy)

We have demonstrated a time-resolved luminescence (TRL) assay for the sensitive and selective detection of thyroglobulin (Tg), a thyroid cancer marker, in homogeneous solution using water-soluble α-D-mannose-conjugated Au nanodots (Man-Au NDs). The Man-Au NDs (1.7 nm in diameter) were prepared from the reaction between Au nanoparticles (2.9 nm in diameter) with 11-mercapto-3,6,9-trioxaundecyl-α-D-mannopyranoside (Man-RSH; 0–10 mM). We have found that the luminescence intensity and lifetimes of Man-Au NDs separately become stronger and longer, respectively, upon increasing the concentration of Man-RSH. The Man-Au NDs possess several interesting optical properties, including long luminescence lifetime (>500 ns) and large Stokes' shift (>150 nm). The TRL assay is based on the competition between Tg and Man-Au NDs for interacting with concanavalin A (Con A). The fluorescence intensities integrated over the region of 50–400 ns increase upon increasing the concentration of Tg over the range 0.1–2.5 nM. The Con A/Man-Au NDs system in a label-free manner allows the detection of Tg at concentrations as low as 90 pM in the presence of BSA at 50 M by TRL. With its advantages of rapid and specificity, this present approach holds great potential for diagnosis of cancers.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: CANCER MARKER; GOLD NANODOTS; LABEL-FREE ASSAYS; PROTEINS; TIME-RESOLVED LUMINESCENCE

Document Type: Research Article

Publication date: October 1, 2009

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more